[ Price : $8.95]
Alzheon says its Phase 3 valiltramiprosate trial in early Alzheimers disease patients did not meet its primary endpoint of slowing...[ Price : $8.95]
FDA clears the Dexcom G7 15 Day continuous glucose monitoring system.[ Price : $8.95]
FDA clears an Intuitive 510(k) for the SP SureForm 45 stapler for use with its da Vinci SP surgical system in thoracic, colorectal...[ Price : $8.95]
Two stakeholders voice support for an FDA draft guidance on using AI in drug and biologic regulatory decision-making and ask for a...[ Price : $8.95]
FDA clears a Zeiss Medical Technology 510(k) for its Intrabeam 700, a robotic-assisted platform to support intraoperative radiatio...[ Price : $8.95]
Hyman, Phelps & McNamara attorney Kurst Karst says recent staff cuts at FDA that eradicated the Office of Generic Drugs Division o...[ Price : $8.95]
FDA accepts for review an Outlook Therapeutics BLA resubmission for ONS-5010 (bevacizumab-vikg), an investigational ophthalmic for...[ Price : $8.95]
The Government Accountability Office says HHS should have some mechanism in place to coordinate the activities of various HHS agen...